 The goal of this clinical research study is to learn if it is safe and practical to give fucosylated Tregs to patients who will receive a matched related donor MRD, a matched unrelated donor MUD, or cord blood transplant. Researchers also want to learn if these Tregs may prevent or reduce the effects of graft-versus host disease GVHD. GVHD can result from a reaction of the transplanted cord blood cells against certain tissues in the body. 